ARTICLE | Company News
Eli Lilly sales and marketing update
June 13, 2016 7:00 AM UTC
The U.K.’s NICE issued draft guidance recommending against the use of Portrazza necitumumab from Eli Lilly to treat advanced or metastatic, squamous non-small cell lung cancer (NSCLC). According to N...